Maravai Lifesciences Holdings (MRVI) Net Income (2020 - 2025)
Maravai Lifesciences Holdings has reported Net Income over the past 6 years, most recently at -$63.0 million for Q4 2025.
- Quarterly results put Net Income at -$63.0 million for Q4 2025, down 36.79% from a year ago — trailing twelve months through Dec 2025 was -$230.8 million (up 11.12% YoY), and the annual figure for FY2025 was -$230.8 million, up 11.12%.
- Net Income for Q4 2025 was -$63.0 million at Maravai Lifesciences Holdings, down from -$45.1 million in the prior quarter.
- Over the last five years, Net Income for MRVI hit a ceiling of $156.7 million in Q2 2022 and a floor of -$172.5 million in Q3 2024.
- Median Net Income over the past 5 years was -$13.5 million (2023), compared with a mean of $16.6 million.
- Biggest five-year swings in Net Income: soared 9227.12% in 2021 and later tumbled 1582.49% in 2024.
- Maravai Lifesciences Holdings' Net Income stood at $127.1 million in 2021, then plummeted by 31.22% to $87.4 million in 2022, then crashed by 225.8% to -$110.0 million in 2023, then soared by 58.11% to -$46.1 million in 2024, then crashed by 36.79% to -$63.0 million in 2025.
- The last three reported values for Net Income were -$63.0 million (Q4 2025), -$45.1 million (Q3 2025), and -$69.8 million (Q2 2025) per Business Quant data.